Argent BioPharma ltd

About Argent BioPharma ltd

Argent BioPharma, an innovative drug discovery company listed on the London Stock Exchange, is enhancing its commitment to accessible medical treatments with advancements in poly pharmacology and nanotechnology.
As a clinical-stage, revenue-generating biopharmaceutical company, we focus on addressing unmet medical needs through cutting-edge research and development.

At Argent Bioph...

  • Country/Region:
    United Kingdom
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
CMO/CDMO
OTC
Pharmaceutical company
Start-up
Primary activities
API Producer
Biopharmaceutical
Custom Manufacturing/Custom Synthesis
OTC
Contact info

Products from Argent BioPharma ltd (3)

  • CimetrA®

    Product CimetrA®

    Early Stage Revenue Generating Immunomodulation Treatment for ARDS CimetrA® delivered 50,000 units to the USA market (Under Special Access) and over 100,000 worldwide, representing over US$2,500,000 in sales to date. Results of Preclinical and Clinical program, meeting FDA guidelines, to date: • Demon...
  • IrniCann®

    Product IrniCann®

    Pre-Clinical Stage Glioblastoma • Innovative pre-clinical stage drug targeting Glioblastoma Multiforme (GBM) Stem Cells, one of the deadliest forms of brain cancer, with the potential to transform treatment outcomes for this aggressive disease​ • An estimated 250,000 new cases of GBM per year worldwide....
  • CannEpil

    Product CannEpil

    CannEpil®, one of Argent BioPharma's flagship products, is an enhanced iteration of a compounded isolated cannabinoid formulation. It leverages well-known historical data to become one of the first compounded prescription investigational drugs used for seizure management over the past years. The active ing...

Argent BioPharma ltd Resources (1)